Assy, Nimer <br/><br/>
Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis.  [electronic resource] 

 -  Gut  Mar 2007 
 - 443-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Letter 
<br/><br/><label>ISSN: </label>0017-5749 
<br/><br/><label>Standard No.: </label>10.1136/gut.2006.106021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Obesity Agents--therapeutic use<br/>Fatty Liver--drug therapy<br/>Female<br/>Humans<br/>Lactones--therapeutic use<br/>Liver Cirrhosis--drug therapy<br/>Male<br/>Middle Aged<br/>Obesity--complications<br/>Orlistat<br/>Treatment Outcome<br/>Weight Loss--drug effects